Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin

Journal of Controlled Release

Volumn 178, Issue 1, 2014, Pages 118-124

  Kim, Hyungjun ^a   Lee, Yonghyun ^b   Lee, In Hyun ^b   Kim, Sunghyun ^b   Kim, Daejin ^b   Saw, Phei Er ^b   Lee, Jinju ^a   Choi, Minsuk ^b   Kim, Yong Chul ^a   Jon, Sangyong ^b  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Aptides; Conjugates; Docetaxel; Drug delivery; Extra domain B; Targeted therapy

Indexed keywords

APTIDES; CONJUGATES; DOCETAXEL; DRUG DELIVERY; EXTRA DOMAIN B; TARGETED THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; FEMALE; FIBRONECTINS; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; TAXOIDS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84894359152     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.01.015     Document Type: Article

References (36)

1. S. Jaracz, J. Chen, L.V. Kuznetsova, and L. Ojima Recent advances in tumor-targeting anticancer drug conjugates Bioorg. Med. Chem. 13 2005 5043 5054
2. S. Muro Challenges in design and characterization of ligand-targeted drug delivery systems J. Control. Release 164 2012 125 137
3. A.M. Wu, and P.D. Senter Arming antibodies: prospects and challenges for immunoconjugates Nat. Biotechnol. 23 2005 1137 1146
4. C.W. Gilbert, E.B. McGowan, G.B. Seery, K.S. Black, and M.D. Pegram Targeted prodrug treatment of HER-2-positive breast tumor cells using trastuzumab and paclitaxel linked by A-Z-CINN Linker J. Exp. Ther. Oncol. 3 2003 27 35
5. A. Safavy, J.A. Bonner, H.W. Waksal, D.J. Buchsbaum, G.Y. Gillespie, M.B. Khazaeli, R. Arani, D.T. Chen, M. Carpenter, and K.P. Raisch Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery Bioconjug. Chem. 14 2003 302 310
6. S. Quiles, K.P. Raisch, L.L. Sanford, J.A. Bonner, and A. Safavy Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy J. Med. Chem. 53 2010 586 594
7. A. Regina, M. Demeule, C. Che, I. Lavallee, J. Poirier, R. Gabathuler, R. Beliveau, and J.P. Castaigne Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2 Br. J. Pharmacol. 155 2008 185 197
8. R. Yamada, M.B. Kostova, R.K. Anchoori, S.L. Xu, N. Neamati, and S.R. Khan Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery Cancer Biol. Ther. 9 2010 192 203
9. W.Y. Tai, R.S. Shukla, B. Qin, B.Y. Li, and K. Cheng Development of a peptide-drug conjugate for prostate cancer therapy Mol. Pharm. 8 2011 901 912
10. S.A. Kularatne, K. Wang, H.K.R. Santhapuram, and P.S. Low Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand Mol. Pharmaceut. 6 2009 780 789
11. S.C. Alley, N.M. Okeley, and P.D. Senter Antibody-drug conjugates: targeted drug delivery for cancer Curr. Opin. Chem. Biol. 14 2010 529 537
12. R. Mahato, W.Y. Tai, and K. Cheng Prodrugs for improving tumor targetability and efficiency Adv. Drug Deliv. Rev. 63 2011 659 670
13. K. Chen, and P.S. Conti Target-specific delivery of peptide-based probes for PET imaging Adv. Drug. Deliver. Rev. 62 2010 1005 1022
14. B.L. Bray Large-scale manufacture of peptide therapeutics by chemical synthesis Nat. Rev. Drug Discov. 2 2003 587 593
15. L. Tang, X. Yang, L.W. Dobrucki, I. Chaudhury, Q. Yin, C. Yao, S. Lezmi, W.G. Helferich, T.M. Fan, and J. Cheng Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors Angew. Chem. Int. Ed. 51 2012 12721 12726
16. K.D. Wittrup, G.M. Thurber, M.M. Schmidt, and J.J. Rhoden Practical theoretic guidance for the design of tumor-targeting agents Methods Enzymol. 503 2012 255 268
17. K.D. Orcutt, J.J. Rhoden, B. Ruiz-Yi, J.V. Frangioni, and K.D. Wittrup Effect of small-molecule-binding affinity on tumor uptake in vivo: a systematic study using a pretargeted bispecific antibody Mol. Cancer Ther. 11 2012 1365 1372
18. E. Ruoslahti, and M.D. Pierschbacher New perspectives in cell-adhesion - Rgd and integrins Science 238 1987 491 497
19. S.S. Dharap, Y. Wang, P. Chandna, J.J. Khandare, B. Qiu, S. Gunaseelan, P.J. Sinko, S. Stein, A. Farmanfarmaian, and T. Minko Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide Proc. Natl. Acad. Sci. U. S. A. 102 2005 12962 12967
20. P. Chandna, M. Saad, Y. Wang, E. Ber, J. Khandare, A.A. Vetcher, V.A. Soldatenkov, and T. Minko Targeted proapoptotic anticancer drug delivery system Mol. Pharm. 4 2007 668 678
21. X.Y. Chen, C. Plasencia, Y.P. Hou, and N. Neamati Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery J. Med. Chem. 48 2005 1098 1106
22. A. Dal Pozzo, M.H. Ni, E. Esposito, S. Dallavalle, L. Musso, A. Bargiotti, C. Pisano, L. Vesci, F. Bucci, M. Castorina, R. Fodera, G. Giannini, C. Aulicino, and S. Penco Novel tumor-targeted RGD peptide-camptothecin conjugates: synthesis and biological evaluation Bioorgan. Med. Chem. 18 2010 64 72
23. M. Pilkington-Miksa, D. Arosio, L. Battistini, L. Belvisi, M. De Matteo, F. Vasile, P. Burreddu, P. Carta, G. Rassu, P. Perego, N. Carenini, F. Zunino, M. De Cesare, V. Castiglioni, E. Scanziani, C. Scolastico, G. Casiraghi, F. Zanardi, and L. Manzoni Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery Bioconjug. Chem. 23 2012 1610 1622
24. C. Zhan, B. Gu, C. Xie, J. Li, Y. Liu, and W. Lu Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect J. Control. Release 143 2010 136 142
25. S. Kim, D. Kim, H.H. Jung, I.H. Lee, J.I. Kim, J.Y. Suh, and S. Jon Bio-inspired design and potential biomedical applications of a novel class of high-affinity peptides Angew. Chem. Int. Ed. 51 2012 1890 1894
26. J. Park, S. Kim, P.E. Saw, I.H. Lee, M.K. Yu, M. Kim, K. Lee, Y.C. Kim, Y.Y. Jeong, and S. Jon Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging J. Control. Release 163 2012 111 118
27. P.E. Saw, S. Kim, I.H. Lee, J. Park, M. Yu, J. Lee, J.I. Kim, and S. Jon Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy J. Mater. Chem. B 1 2013 4723 4726
28. R.A. Walker, J.L. Jones, S. Chappell, T. Walsh, and J.A. Shaw Molecular pathology of breast cancer and its application to clinical management Cancer Metastasis Rev. 16 1997 5 27
29. A. Ardavanis, D. Tryfonopoulos, I. Yiotis, G. Gerasimidis, N. Baziotis, and G. Rigatos Non-allergic nature of docetaxel-induced acute hypersensitivity reactions Anti-cancer drugs 15 2004 581 585
30. A.J. ten Tije, J. Verweij, W.J. Loos, and A. Sparreboom Pharmacological effects of formulation vehicles - implications for cancer chemotherapy Clin. Pharmacokinet. 42 2003 665 685
31. L. van Zuylen, J. Verweij, and A. Sparreboom Role of formulation vehicles in taxane pharmacology Invest. New Drugs 19 2001 125 141
32. E. Lee, H. Kim, I.H. Lee, and S. Jon In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration J. Control. Release 140 2009 79 85
33. A. Warnecke, and F. Kratz Maleimide-oligo(ethylene glycol) derivatives of camptothecin as albumin-binding prodrugs: synthesis and antitumor efficacy Bioconjugate. Chem. 14 2003 377 387
34. A. Safavy, G.I. Georg, D. Vander Velde, K.P. Raisch, K. Safavy, M. Carpenter, W. Wang, J.A. Bonner, M.B. Khazaeli, and D.J. Buchsbaum Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure Bioconjugate. Chem. 15 2004 1264 1274
35. M. Longmire, P.L. Choyke, and H. Kobayashi Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats Nanomedicine 3 2008 703 717
36. S.C. Kim, D.W. Kim, Y.H. Shim, J.S. Bang, H.S. Oh, S. Wan Kim, and M.H. Seo In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy J. Control. Release 72 2001 191 202